Flavonoids from Artemisia annua L. As antioxidants and their potential synergism with artemisinin against malaria and cancer

Molecules

Volumn 15, Issue 5, 2010, Pages 3135-3170

  Ferreira, Jorge F S ^a   Luthria, Devanand L ^b   Sasaki, Tomikazu ^c   Heyerick, Arne ^d  

^a APPALACHIAN FARMING SYSTEMS RESEARCH CENTER   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Anticancer; Antimalarial; Artemisia annua; Artemisinin; Flavonoids; Synergism

Indexed keywords

ANTIOXIDANT; ARTEMISININ DERIVATIVE; FLAVONOID;

ARTEMISIA ANNUA; CHEMISTRY; DRUG COMBINATION; DRUG POTENTIATION; HUMAN; MALARIA; NEOPLASM; REVIEW; NEOPLASMS;

ANTIOXIDANTS; ARTEMISIA ANNUA; ARTEMISININS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FLAVONOIDS; HUMANS; MALARIA; NEOPLASMS;

EID: 77952827501     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15053135     Document Type: Review

References (179)

1. Mabeza, G.F.; Loyevsky, M.; Gordeuk, V.R.; Weiss, G. Iron chelation therapy for malaria: a review. Pharmacol. Therapeut. 1999, 81, 53-75.
2. Tsao, R.; Deng, Z. Separation procedures for naturally occurring antioxidant phytochemicals. J. Chromat. B 2004, 812, 85-99.
3. Efferth, T.; Benakis, A.; Romero, M.R.; Tomicic, M.; Rauh, R.; Steinbach, D.; Häfer, R.; Stamminger, T.; Oesch, F.; Kaina, B.; Marschall, M. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Rad. Biol. Med. 2004, 37, 998-1009.
4. Erel, O.; Vural, H.; Aksoy, N.; Aslan, G.; Ulukanligil, M. Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria. Clin. Biochem. 2001, 34, 341-344.
5. Valko, M.; Rhodes, C.J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biologic. Interact. 2006, 160, 1-40.
6. Willcox, M.; Falquet, J.; Ferreira, J.F.S.; Gilbert, B.; Hsu, E.; Magalhães, P.M.; Plaizier- Vercammen, J.; Sharma, V.P.; Wright, C.W.; Yaode, W. Artemisia annua as an herbal tea for malaria. African J. Trad. Complem. Altern. Med. 2007, 4, 121-123.
7. Rath, K.; Taxis, K.; Walz, G.; Gleiter, C.H.; Li, S.-M.; Heide, L. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am. J. Trop. Med. Hyg. 2004, 70, 128-132.
8. Blanke, C.H.; Naisabha, G.B.; Balema, M.B.; Mbaruku, G.M.; Heide, L.; Muller, M.S. Herba Artemisiae annuae tea preparation compared to sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria in adults: a randomized double-blind clinical trial. Trop. Doct. 2008, 38, 113-116.
9. Ittarat, W.; Pickard, A.L.; Rattanasinganchan, P.; Wilairatana, P.; Looareesuwan, S.; Emery, K.; Low, J.; Udomsangpetch, R.; Meshnick, S.R. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. Am. J. Trop. Med. Hyg. 2003, 68, 147-152.
10. Price, R.; van Vugt, M.; Nosten, F.; Luxemburger, C.; Brockman, A.; Phaipun, L.; Chongsuphajaisiddhi, T.; White, N. Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria. Am. J. Trop. Med. Hyg. 1998, 59, 883-888. (Pubitemid 29028916)
11. Menard, D.; Matsika-Claquin, M.D.; Djalle, D.; Yapou, F.; Manirakiza, A.; Dolmazon, V.; Sarda, J.; Talarmin, A. Association of failures of seven-day courses of artesunate in a nonimmune population in Bangui, Central African Republic with decreased sensitivity to Plasmodium falciparum. Am. J. Trop. Med. Hyg. 2005, 73, 616-621.
12. Hsu, E. Reflections on the 'discovery' of the antimalarial qinghao. Brit. J. Clin. Pharmacol. 2006, 61, 666-670.
13. Quideau, S. Why bother with polyphenols? In Groupe Polyphenols: The International Society Dedicated to the Promotion of Research on Polyphenols; Bordeaux, France, 2009.
14. Luthria, D.L.; Mukhopadhyay, S.; Krizek, D.T. Content of total phenolics and phenolic acids in tomato (Lycopersicon esculentum Mill.) fruits as influenced by cultivar and solar UV radiation. J. Food Comp. Anal. 2006, 19, 771-777.
15. Naczk, M.; Shahidi, F. Extraction and analysis of phenolics in food. J. Chrom. A 2004, 1054, 95-111.
16. George, T.W.; Niwat, C.; Waroonphan, S.; Gordon, M.H.; Lovegrove, J.A.; Paterson, E. Effect of chronic and acute fruit and vegetable juice consumption on cardiovascular disease risk factor. Acta Hort. 2009, 841, 201-206.
17. Aggarwal, B.B. Targeting inflammatory pathways for chronic diseases by phytochemicals derived from spices, fruits, vegetables, and traditional remedies. Acta Hort. 2009, 841, 33-46.
18. Luthria, D.L. Significance of sample preparation in developing analytical methodologies for accurate estimation of bioactive compounds in functional foods. J. Sci. Food Agric. 2006, 86, 2266-2272.
19. Robbins, R.J. Phenolic acids in foods: an overview of analytical methodology. J. Agric. Food Chem. 2003, 51, 2866-2887.
20. Croteau, R.; Kutchan, T.M.; Lewis, N.G. Natural products (secondary metabolites). In Biochemistry & Molecular Biology of Plants; Buchanan, B.R., Jones, W.G., Eds.; American Society of Plant Physiologists: Rockville, MD, USA, 2000; pp. 1250-1318.
21. Antolovich, M.; Prenzler, P.; Robards, K.; Ryan, D. Sample preparation in the determination of phenolic compounds in fruits. Analyst 2000, 125, 989-1009.
22. Escarpa, A.; Gonzalez, M.C. An overview of analytical chemistry of phenolic compounds in foods. Crit. Rev.Analyt. Chem. 2001, 31, 57-139.
23. Brisibe, E.A.; Umoren, U.E.; Brisibe, F.; Magalhaes, P.M.; Ferreira, J.F.S.; Luthria, D.; Wu, X.; Prior, R.L. Nutritional characterisation and antioxidant capacity of different tissues of Artemisia annua L. Food Chem. 2009, 115, 1240-1246.
24. Zheng, W.; Wang, S.Y. Antioxidant activity and phenolic compounds in selected herbs. J. Agric. Food Chem. 2001, 49, 5165 - 5170.
25. Lai, J.-P.; Lim, Y.H.; Su, J.; Shen, H.-M.; Ong, C.N. Identification and characterization of major flavonoids and caffeoylquinic acids in three Compositae plants by LC/DAD-APCI/MS. J. Chrom. B 2007, 848, 215-225.
26. Brown, G.D. Two new compounds from Artemisia annua. J. Nat. Prod. 1992, 55, 1756-1760.
27. Bhakuni, R.S.; Jain, D.C.; Sharma, R.P.; Kumar, S. Secondary metabolites of Artemisia annua and their biological activity. Curr. Sci. 2001, 80, 35-48.
28. Elford, B.C.; Roberts, M.F.; Phillipson, J.D.; Wilson, R.J. Potentiation of the antimalarial activity of qinghaosu by methoxylated flavones. Trans. R. Soc. Trop. Med. Hyg. 1987, 81, 434-436.
29. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad. Biol. Med. 1996, 20, 933-956.
30. Liersch, R.; Soicke, H.; Stehr, C.; Tullner Formation of artemisinin in Artemisia annua during one vegetation period. Planta Med. 1986, 52, 387-390.
31. Luo, S.D.; B.M., N.; Hu, W.Y.; Xie, J.L. Studies on peroxides of Artemisia lamcea. J. Nat. Prod. 1991, 54 573-575.
32. Marchese, J.A.; Broetto, F.; Ming, L.C.; Ducatti, C.; Rodella, R.A.; Ventrella, M.C.; Gomes, G.D.R.; de Franceschi, L. Carbon isotope composition and leaf anatomy as a tool to characterize the photosynthetic mechanism of Artemisia annua L. Braz. J. Plant Phys. 2005, 17, 187-190.
33. Ferreira, J.F.S.; Laughlin, J.C.; Delabays, N.; Magalhães, P.M. Cultivation and genetics of Artemisia annua for increased production of the anti-malarial artemisinin. Plant Gen. Resourc. 2005, 3, 206-229.
34. Baraldi, R.; Isacchi, B.; Predieri, S.; Marconi, G.; Vincieri, F.F.; Bilia, A.R. Distribution of artemisinin and bioactive flavonoids from Artemisia annua L. during plant growth. Biochem. Syst. Ecol. 2008, 36, 340-348.
35. Ferreira, J.F.S.; Simon, J.E.; Janick, J. Developmental studies of Artemisia annua: Flowering and artemisinin production under greenhouse and field conditions. Planta Med. 1995, 67, 167-170.
36. Ferreira, J.F.S. Seasonal and post-harvest accumulation of artemisinin, artemisinic acid, and dihydroartemisinic acid in three accessions of Artemisia annua cultivated in West Virginia, USA. Planta Med. 2008, 74, 310-311.
37. Wallaart, T.E.; Pras, N.; Quax, W.J. Seasonal variations of artemisinin and its biosynthetic precursors in tetraploid Artemisia annua plants compared with diploid wild-type. Planta Med. 1999, 65, 723-728.
38. Bilia, A.R.; Magalhães, P.M.; Bergonzi, M.C.; Vincieria, F.F. Simultaneous analysis of artemisinin and flavonoids of several extracts of Artemisia annua L. obtained from a commercial sample and a selected cultivar. Phytomedicine 2006, 73, 487-493.
39. Ferreira, J.F.S. Artemisia species in small ruminant production: their potential antioxidant and anthelmintic effects. In Appalachian Workshop and Research Update: Improving small ruminant grazing practices; Morales, M., Ed.; Mountain State University/USDA: Beaver, WV, USA, 2009; pp. 53-70.
40. Ro, D.-K.; Paradise, E.M.; Ouellet, M.; Fisher, K.J.; Newman, K.L.; Ndungu, J.M.; Ho, K.A.; Eachus, R.A.; Ham, T.S.; Kirby, J.; Chang, M.C.Y.; Withers, S.T.; Shiba, Y.; Sarpong, R.; Keasling, J.D. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440, 940-943.
41. Wallaart, T.E.; Pras, N.; Beekman, A.C.; Quax, W.J. Seasonal variation of artemisinin and its biosynthetic precursors in plants of Artemisia annua of different geographical origin: Proof for the existence of chemotypes. Planta Med. 2000, 66, 57-62.
42. Le Marchand, L.; Murphy, S.P.; Hankin, J.H.; Wilkens, L.R.; Kolonel, L.N. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst. 2000, 92, 154-160.
43. Walle, T. Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin. Cancer Biol. 2007, 77, 354-362.
44. Myhrstad, M.C.W.; Carlsen, H.; Nordström, O.; Blomhoff, R.; Moskaug, J.Ø. Flavonoids increase the intracellular glutathione level by transactivation of the [gamma]-glutamylcysteine synthetase catalytical subunit promoter. Free Rad. Biol. Med. 2002, 32, 386-393.
45. Nakamura, Y.; Miyoshi, N. Electrophiles in foods: The current status of isothiocyanates and their chemical biology. Biosci. Biotechnol. Biochem. 2010, 74, 242-255.
46. Moskaug, J.O.; Carlsen, H.; Myhrstad, M.C.W.; Blomhoff, R. Polyphenols and glutathione synthesis regulation. Am. J. Clin. Nutr. 2005, 87, 277S-283S.
47. Yokoyama, A.; Sakakibara, H.; Crozier, A.; Kawai, Y.; Matsui, A.; Terao, J.; Kumazawa, S.; Shimoi, K. Quercetin metabolites and protection against peroxynitrite-induced oxidative hepatic injury in rats. Free Rad. Res. 2009, 43, 913-921.
48. Suri, S.; Liu, X.H.; Rayment, S.; Hughes, D.A.; Kroon, P.A.; Needs, P.W.; Taylor, M.A.; Tribolo, S.; Wilson, V.G. Quercetin and its major metabolites selectively modulate cyclic GMPdependent relaxations and associated tolerance in pig isolated coronary artery. Brit. J. Pharmacol. 2009, 159, 566-575.
49. Liao, H.; Banbury, L.K.; Leach, D.N. Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics. eCAM 2008, 5, 429-434.
50. Willcox, M.; Falquet, J.; Ferreira, J.F.S.; Gilbert, B.; Hsu, E.; Magalhães, P.M.; Plaizier- Vercammen, J.; Sharma, V.P.; Wright, C.W.; Yaode, W. Artemisia annua as a herbal tea for malaria. Afr. J. Trad. CAM 2007, 4, 121-123.
51. Monbrison, F.; Maitrejean, M.; Latour, C.; Bugnazet, F.; Peyron, F.; Barron, D.; Picot, S. In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide. Acta Trop. 2006, 97, 102-107.
52. Silveira, P.; Vashist, U.; Cabral, A.; Amaral, K.; Soares, G.; Dagosto, M. Effect of rutin and chloroquine on White Leghorn chickens infected with Plasmodium (Bennettinia) juxtanucleare. Trop. Anim. Health Produc. 2009.
53. Lehane, A.; Saliba, K. Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite. BMC Res. Notes 2008, 1, 26.
54. Willcox, M. Artemisia species: from traditional medicines to modern antimalarials-and back again. JACM 2009, 15, 101-109.
55. Hollman, P.C.H.; Gaag, M.V.D.; Mengelers, M.J.B.; Van Trijp, J.M.P.; De Vries, J.H.M.; Katan, M.B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Rad. Biol. Med. 1996, 21, 703-707.
56. Bilia, A.R.; Lazari, D.; Messori, L.; Taglioli, V.; Temperini, C.; Vincieri, F.F. Simple and rapid physico-chemical methods to examine action of antimalarial drugs with hemin: Its application to Artemisia annua constituents. Life Sci. 2002, 70, 769-778.
57. Liu, K.C.-S.; Yang, S.-L.; Roberts, M.E.; Elford, B.C.; Phillipson, J.D. Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures. Plant Cell Rep. 1992, 11, 637-640.
58. Bilia, A.R.; Sannella, A.R.; Vincieri, F.F.; Messori, L.; Casini, A.; Gabbiani, C.; Severini, C.; Majori, G. Antiplasmodial effects of a few selected natural flavonoids and their modulation of artemisinin activity. Nat. Prod. Commun. 2008, 3, 1999-2002.
59. Lu, J.; Papp, L.V.; Fang, J.; Rodriguez-Nieto, S.; Zhivotovsky, B.; Holmgren, A. Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res. 2006, 66, 4410-4418.
60. Krnajski, Z.; Gilberger, T.W.; Walter, R.D.; Cowman, A.F.; Müller, S. Thioredoxin reductase is essential for the survival of Plasmodium falciparum erythrocytic stages. J. Biolog. Chem. 2002, 277, 25970-25975.
61. Kun, J.F.J.; Hibbs, A.R.; Saul, A.; McColl, D.J.; Coppel, R.L.; Anders, R.F. A putative Plasmodium falciparum exported serine/threonine protein kinase. Mol. Biochem. Parasitol. 1997, 85, 41-51.
62. Kale, A.; Gawande, S.; Kotwal, S. Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytoth. Res. 2008, 22, 567-577.
63. Arts, I.C.W. A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J. Nutr. 2008, 138, 1561S-1566S.
64. Le Marchand, L. Cancer preventive effects of flavonoids-a review. Biomed. Pharmacother. 2002, 56, 296-301.
65. Nijveldt, R.J.; van Nood, E.; van Hoorn, D.E.C.; Boelens, P.G.; van Norren, K.; van Leeuwen, P.A.M. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001, 74, 418-425.
66. Lai, H.; Singh, N.P. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 1995, 91, 41-46.
67. Moore, J.C.; Lai, H.; Li, J.-R.; Ren, R.-L.; McDougall, J.A.; Singh, N.P.; Chou, C.-K. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett. 1995, 98, 83-87.
68. Efferth, T.; Dunstan, H.; Sauerbrey, A.; Miyachi, H.; Chitambar, C.R. The anti-malarial artesunate is also active against cancer. Int. J. Oncol. 2001, 18, 767-773.
69. Singh, N.P.; Lai, H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci. 2001, 70, 49-56.
70. Lai, H.; Sasaki, T.; Singh, N.P.; Messay, A. Effects of artemisinin-tagged holotrasferrin on cancer cells. Life Sci. 2005, 76, 1267-1279.
71. Nakase, I.; Gallis, B.; Takatani-Nakase, T.; Oh, S.; Lacoste, E.; Singh, N.P.; Goodlett, D.R.; Tanaka, S.; Futaki, S.; Lai, H.; Sasaki, T. Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett. 2009, 274, 290-298.
72. Oh, S.; Kim, B.J.; Singh, N.P.; Lai, H.; Sasaki, T. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Cancer Lett. 2009, 274, 33-39.
73. Firestone, G.L.; Sundar, S.N. Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev. Mol. Med. 2009, 11, 1-15.
74. Beutler, J.A.; Hamel, E.; Vlietinck, A.J.; Haemers, A.; Rajan, P.; Roitman, J.N.; Cardellina II, J.H.; Boyd, M.R. Structure-Activity Requirements for Flavone Cytotoxicity and Binding to Tubulin. J. Med. Chem. 1998, 41, 2333-2338.
75. Henrich, C.J.; Bokesch, H.R.; Dean, M.; Bates, S.E.; Robey, R.W.; Goncharova, E.I.; Wilson, J.A.; McMahon, J.B. A yigh-throughput cell-based assay for inhibitors of ABCG2 activity. J. Biomolec. Screen. 2006, 11, 176-183.
76. Zhou, L.; Liu, P.; Chen, B.; Wang, Y.; Wang, X.; Internati, M.C.; Wachtel, M.S.; Frezza, E.E. Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells. Anticancer Res. 2008, 28, 1119-1127.
77. Son, Y.-G.; Kim, E.H.; Kim, J.Y.; Kim, S.U.; Kwon, T.K.; Yoon, A.-R.; Yun, C.-O.; Choi, K.S. Silibinin Sensitizes Human Glioma Cells to TRAIL-Mediated Apoptosis via DR5 Up-regulation and Down-regulation of c-FLIP and Survivin. Cancer Res. 2007, 67, 8274-8284.
78. Imai, Y.; Tsukahara, S.; Asada, S.; Sugimoto, Y. Phytoestrogens/ Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance. Cancer Res. 2004, 64, 346-4352.
79. Dhanalakshmi, S.; Agarwal, P.; Glode, L.M.; Agarwal, R. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death. Int. J. Cancer 2003, 106, 699-705.
80. Kim, J.Y.; Kim, E.H.; Park, S.S.; Lim, J.H.; Kwon, T.K.; Choi, K.S. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Spl-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. J. Cell Biochem. 2008, 105, 1386-1398.
81. Chan, M.M.; Fong, D. Overcoming ovarian cancer drug resistance with phytochemicals and other compounds. Prog. Cancer Drug Resist. Res. 2007, 1-28.
82. Zanini, C. Giribaldi, G.; Mandili, G.; Carta, F.; Crescenzio, N.; Bisaro, B.; Doria, A.; Foglia, L.; Cordero di Montezemolo, L.; Timeus, F.; Turrini, F. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines. J. Neurochem. 2007, 103, 1344-1354.
83. Limtrakul, P.; Khantamat, O.; Pintha, K. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J. Chemother. 2005, 17, 86-95.
84. Sliutz, G.; Karlseder, J.; Tempfer, C.; Orel, L.; Holzer, G.; Simon, M.M. Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: Implication of quercetin as sensitizer in chemotherapy. Brit. J. Cancer 1996, 74, 172-177.
85. Szliszka, E.; Czuba, Z.P.; Jernas, K.; Krol, W. Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Int. J. Mol. Sci. 2008, 9, 56-64.
86. Horinaka, M.; Yoshida, T.; Shiraishi, T.; Nakata, S.; Wakada, M.; Sakai, T. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis- inducing ligand. Mol. Cancer Ther. 2006, 5, 945-951.
87. Long, X.; Fan, M.; Bigsby, R.M.; Nephew, K.P. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha- independent mechanisms. Mol. Cancer Ther. 2008, 7, 2096-2108.
88. Chiang, C.-T.; Way, T.-D.; Lin, J.-K. Sensitizing HER2-overexpressing cancer cells to luteolin- induced apoptosis through suppressing p21WAF1/CIP1 expression with rapamycin. Mol. Cancer Ther. 2007, 6, 2127-2138.
89. Du, G.-J.; Song, Z.-H.; Lin, H.-H.; Han, X.-F.; Zhang, S.; Yang, Y.-M. Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells. Biochim. Biophys. Acta Res. Commun. 2008, 372, 497-502.
90. Shi, R.; Huang, Q.; Zhu, X.; Ong, Y.-B.; Zhao, B.; Lu, J.; Ong, C.-N.; Shen, H.-M. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol. Cancer Ther. 2007, 6, 1338-1347.
91. Shi, R.-X.; Ong, C.-N.; Shen, H.-M. Protein Kinase C Inhibition and X-Linked Inhibitor of Apoptosis Protein Degradation Contribute to the Sensitization Effect of Luteolin on Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Cancer Cells. Cancer Res. 2005, 65, 7815-7823.
92. Siegelin, M.D.; Reuss, D.E.; Habel, A.; Herold-Mende, C.; von Deimling, A. The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Mol. Cancer Ther. 2008, 7, 3566-3574.
93. Yoshida, T.; Konishi, M.; Horinaka, M.; Yasuda, T.; Goda, A.E.; Taniguchi, H.; Yano, K.; Wakada, M.; Sakai, T. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem. Biophys. Res. Commun. 2008, 375, 129-133.
94. Michelis, F.; Tiligada, E.; Skaltsa, H.; Lazari, D.; Skaltsounis, A.-L.; Delitheos, A. Effects of the flavonoid pilloin isolated from Marrubium cylleneum on mitogen-induced lymphocyte transformation. Pharmaceut. Biol. 2002, 40, 245-248.
95. Patel, D.; Shukla, S.; Gupta, S. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int. J. Oncol. 2007, 30, 233-245.
96. Li, Z.-D.; Hu, X.-W.; Wang, Y.-T.; Fang, J. Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. FEBS Lett. 2009, 582, 1999-2003.
97. Melstrom, L.G.; Salabat, M.R.; Ding, X.-Z.; Milam, B.M.; Strouch, M.; Pelling, J.C.; Bentrem, D.J. Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells. Pancreas 2008, 37, 426-431.
98. Lin, Y.; Shi, R.; Wang, X.; Shen, H.-M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets 2008, 8, 634-646.
99. Seelinger, G.; Merfort, I.; Woelfle, U.; Schempp, C.M. Anti-carcinogenic effects of the flavonoid luteolin. Molecules 2008, 73, 2628-2651.
100. Yoo, D.R.; Jang, Y.H.; Jeon, Y.K.; Kim, J.Y.; Jeon, W.; Choi, Y.J.; Nam, M.J. Proteomic identification of anti-cancer proteins in luteolin-treated human hepatoma Huh-7 cells. Cancer Lett. 2009, 282, 48-54.
101. Nagao, T.; Abe, F.; Kinjo, J.; Okabe, H. Antiproliferative constituents in plants 10. Flavones from the leaves of Lantana montevidensis Briq. and consideration of structure-activity relationship. Biol. Pharm. Bull. 2002, 25, 875-879.
102. Tezuka, Y.; Stampoulis, P.; Banskota, A.H.; Awale, S.; Tran, K.Q.; Saiki, I.; Kadota, S. Constituents of the vietnamese medicinal plant Orthosiphon stamineus. Chem. Pharm. Bull. 2000, 48, 1711-1719.
103. Dobberstein, R.H.; Tin-Wa, M.; Fong, H.H.S.; Crane, F.A.; Farnsworth, N.R. Flavonoid constituents from Eupatorium altissimum L. (Compositae). J. Pharm. Sci. 1977, 66, 600-602.
104. Androutsopoulos, V.P.; Arroo, R.R.J.; F., H.J.; Surichan, S.; A., P.G. Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. Breast Cancer Res. 2008, 70, R39.
105. Androutsopoulos, V.P.; Li, N.; Arroo, R.R.J. The methoxylated flavones eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells. J. Nat. Prod. 2009, 72, 1390-1394.
106. Nagao, T.; Abe, F.; Kinjo, J.; Okabe, H. Antiproliferative constituents in plants 10. Flavones from the leaves of Lantana montevidensis Briq. and consideration of structure-activity relationship. Biol. Pharm. Bull. 2002, 25, 875-879.
107. Sheng, X.; Sun, Y.; Yin, Y.; Chen, T.; Xu, Q. Cirsilineol inhibits proliferation of cancer cells by inducing apoptosis via mitochondrial pathway. J. Pharm. Pharmacol. 2008, 60, 1523-1529.
108. Beutler, J.A.; Hamel, E.; Vlietinck, A.J.; Haemers, A.; Rajan, P.; Roitman, J.N.; Cardellina II, J.H.; Boyd, M.R. Structure-activity requirements for flavone cytotoxicity and binding to tubulin. J. Med. Chem. 1998, 47, 2333-2338.
109. Bai, N.; Zhou, Z.; Zhu, N.; Zhang, L.; Quan, Z.; He, K.; Zheng, Q.Y.; Ho, C.-T. Antioxidant flavonoids from the flower of Inula britannica. J. Food Lip. 2005, 72, 141-149.
110. Henrich, C.J.; Bokesch, H.R.; Dean, M.; Bates, S.E.; Robey, R.W.; Goncharova, E.I.; Wilson, J.A.; McMahon, J.B. A high-throughput cell-based assay for inhibitors of ABCG2 activity. J. Biomol. Screen. 2006, 77, 176-183.
111. So, F.V.; Guthrie, N.; Chambers, A.F.; Carroll, K.K. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. 1997, 112, 127-133. (Pubitemid 27104286)
112. Rodgers, E.H.; Grant, M.H. The effect of the flavonoids quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. Chemico-Biol. Interact. 1998, 116, 213-228.
113. Wenzel, U.; Herzog, A.; Kuntz, S.; Daniel, H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics 2004, 4, 2160-2174. (Pubitemid 38880380)
114. Scambia, G.; Ranelletti, F.O.; Panici, P.B.; Bonanno, G.; Vencenzo, R.D.; Piantelli, M.; Mancuso, S. Synergistic Antiproleferative Activity of Quercetin and Cisplatin on Ovarian Cancer Cell Growth. Anti-Cancer Drugs 1990, 1, 45-48.
115. Ranelletti, F.O.; Ricci, R.; Larocca, L.M.; Maggiano, N.; Capelli, A.; Scambia, G.; Benedetti- Panici, P.; Mancuso, S.; Rumi, C.; Piantelli, M. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int. J. Cancer. 2006, 50, 486-492.
116. Chowdhury, S.A.; Kishino, K.; Satoh, R.; Hashimoto, K.; Kikuchi, H.; Nishikawa, H.; Shirataki, Y.; Sakagami, H. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res. 2005, 25, 2055-2063.
117. Zheng, G.Q. Cytotoxic terpenoids and flavonoids from Artemisia annua. Planta Med. 1994, 60, 54-57.
118. Holder, H.; Zemskova, M.; Zhang, C.; Tabrizizad, M.; Bremer, R.; Neidigh, J.W.; Lilly, M.B. Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol. Cancer Ther. 2007, 6, 163-172.
119. Knockaert, M.; Greengard, P.; Meijer, L. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 2002, 23, 417-425.
120. Chin, Y.-W.; Jones, W.P.; Mi, Q.; Rachman, I.; Riswan, S.; Kardono, L.B.S.; Chai, H.-B.; Farnsworth, N.R.; Cordell, G.A.; Swanson, S.M.; Cassady, J.M.; Kinghorn, A.D. Cytotoxic clerodane diterpenoids from the leaves of Premna tomentosa. Phytochemistry 2006, 67, 1243-1248.
121. Ono, M.; Yanaka, T.; Yamamoto, M.; Ito, Y.; Nohara, T. New diterpenes and norditerpenes from the fruits of Vitex rotundifolia. J. Nat. Prod. 2002, 65, 537-541.
122. Kobayakawa, J.; Sato-Nishimori, F.; Moriyasu, M.; Matsukawa, Y. G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.). Cancer Lett. 2004, 205, 59-64.
123. Haidara, K.; Zamir, L.; Shi, Q.-W.; Batist, G. The flavonoid casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett. 2006, 242, 180-190.
124. Svensson, U.S.; Sandstrom, R.; Carlborg, O.; Lennernas, H.; Ashton, M. High in situ rat intestinal permeability of artemisinin unaffected by multile dosing and with no evidence of P- glycoprotein involvement. Drug Metab. Disp. 1999, 27, 227-232.
125. Li, S.; Pan, M.-H.; Lai, C.-S.; Lo, C.-Y.; Dushenkov, S.; Ho, C.-T. Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines. Bioorg. Med. Chem. 2007, 15, 3381-3389.
126. Arisawa, M.; Hayashi, T.; Shimizu, M.; Morita, N.; Bai, H.; Kuze, S.; Ito, Y. Isolation and cytotoxicity of two new flavonoids from Chrysosplenium grayanum and related flavonols. J. Nat. Prod. 1991, 54, 898-901.
127. Arisawa, M.; Shimizu, M.; Satomi, Y.; Nishino, A.; Nishino, H.; Iwashima, A. Inhibition of tumor-promoter-enhanced 32Pi-incorporation into cellular phospholipids by flavonols from genus Chrysosplenium. Phytother. Res. 1995, 9, 222-224.
128. Mori, A.; Nishino, C.; Enoki, N.; Tawata, S. Cytotoxicity of plant flavonoids against HeLa cells. Phytochemistry 1988, 27, 1017-1020.
129. Mutoh, M.; Takahashi, M.; Fukuda, K.; Komatsu, H.; Enya, T.; Matsushima-Hibiya, Y.; Mutoh, H.; Sugimura, T.; Wakabayashi, K. Suppression by flavonoids of cyclooxygenase-2 promoter- dependent transcriptional activity in colon cancer cells: structure-activity relationship. Jpn. J. Cancer Res. 2000, 97, 686-691. (Pubitemid 30612352)
130. Manthey, J.A.; Guthrie, N. Antiproliferative Activities of Citrus Flavonoids against Six Human Cancer Cell Lines. J. Agric. Food Chem. 2002, 50, 5837-5843.
131. Lee, J.-Y.; Jeong, K.-W.; Kim, W.; Heo, Y.S.; Kim, Y. Binding Models of Flavonols to Human Vascular Endothelial Growth Factor Receptor 2. Bull. Korean Chem. Soc. 2009, 30, 2083-2086.
132. Luo, H.; Rankin, G.O.; Liu, L.; Daddysman, M.K.; Jiang, B.-H.; Chen, Y.C. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr. Cancer 2009, 67, 554-563.
133. Kang, G.-Y.; Lee, E.-R.; Kim, J.-H.; Jung, J.W.; Lim, J.; Kim, S.K.; Cho, S.-G.; Kim, K.P. Downregulation of PLK-1 expression in kaempferol-induced apoptosis of MCF-7 cells. Eur. J. Pharmacol. 2009, 677, 17-21.
134. Chung, S.Y.; Jang, D.S.; Han, A.-R.; Jang, J.O.; Kwon, Y.; Seo, E.-K.; Lee, H.J. Modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet. Phytother. Res. 2007, 27, 565-569.
135. Choi, E.J.; Ahn, W.S. Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. Nutr. Res. Pract. 2008, 2, 322-325.
136. Labbe, D.; Provencal, M.; Lamy, S.; Boivin, D.; Gingras, D.; Beliveau, R. The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J. Nutr. 2009, 739, 646-652.
137. Zhang, Y.; Chen, A.Y.; Li, M.; Chen, C.; Yao, Q. Ginkgo biloba extract kaempferol Inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J. Surg. Res. 2008, 748, 17-23.
138. Bandyopadhyay, S.; Romero, J.R.; Chattopadhyay, N. Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells. Mol. Cell. Endocrinol. 2008, 287, 57-64.
139. Leung, H.W.-C.; Lin, C.-J.; Hour, M.-J.; Yang, W.-H.; Wang, M.-Y.; Lee, H.-Z. Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes. Food Chem. Tox. 2007, 45, 2005-2013.
140. Teng, B.-S.; Lu, Y.-H.; Wang, Z.-T.; Tao, X.-Y.; Wei, D.-Z. In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells. Pharmacol. Res. 2006, 54, 186-194.
141. Ma, G.; Yang, C.; Qu, Y.; Wei, H.; Zhang, T.; Zhang, N. The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells. Chemico-Biol. Interact. 2007, 167, 153-160.
142. Lee, H.-J.; Lee, H.-J.; Lee, E.-O.; Ko, S.-G.; Bae, H.-S.; Kim, C.-H.; Ahn, K.-S.; Lu, J.; Kim, S.- H. Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Lett. 2008, 270, 342-353.
143. De Leo, M.; Braca, A.; Sanogo, R.; Cardile, V.; DeTommasi, N.; Russo, A. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells. Planta Med. 2006, 72, 604-610.
144. Woerdenbag, H.J.; Merfort, I.; Passreiter, C.M.; Schmidt, T.J.; Willuhn, G.; van Uden, W.; Pras, N.; Kampinga, H.H.; Konings, A.W.T. Cytotoxicity of flavonoids and sesquiterpene lactones from Arnica species against the GLC4 and the COLO 320 cell lines. Planta Med. 1994, 60, 434-437.
145. Matsubara, K.; Ishihara, K.; Mizushina, Y.; Mori, M.; Nakajima, N. Anti-angiogenic activity of quercetin and its derivatives. Lett. Drug Design Disc. 2004, 1, 329-333.
146. Wright, C.W.; Warhurst, D.C. The mode of action of artemisinin and its derivatives. In Artemisia; Wright, C.W., Ed.; Taylor & Francis Inc.: New York, NY, USA, 2002; pp. 249-288.
147. Hein, E.-M.; Rose, K.; van't Slot, G.; Friedrich, A.W.; Humpf, H.-U. Deconjugation and degradation of flavonol glycosides by pig cecal microbiota characterized by fluorescence in situ hybridization (FISH). J. Agric. Food Chem. 2008, 56, 2281-2290.
148. Konishi, Y.; Kobayashi, S.; Shimizu, M. Tea polyphenols inhibit the transport of dietary phenolic acids mediated by the monocarboxylic acid transporter (MCT) in intestinal caco-2 cell monolayers. J. Agric. Food Chem. 2003, 51, 7296-7302.
149. Van't Slot, G.; Humpf, H.-U. Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model. J. Agric.Food Chem. 2009, 57, 8041-8048.
150. Abrahamse, S.L.; Kloots, W.J.; van Amelsvoort, J.M.M. Absorption, distribution, and secretion of epicatechin and quercetin in the rat. Nutr. Res. 2005, 25, 305-317.
151. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
152. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
153. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005, 81, 243S-255S.
154. Svensson, U.S.H.; Ashton, M. Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br. J. Clin. Pharmacol. 1999, 48, 528-535.
155. Batty, K.T.; Thu, L.T.A.; Davis, T.M.E.; Ilett, K.F.; Mai, T.X.; Hung, N.C.; Tien, N.P.; Powell, S.M.; Thien, H.V.; Binh, T.Q.; Kim, N.V. A pharmacokinetic and pharmacodynamic study of intravenous vs. oral artesunate in uncomplicated falciparum malaria. Br. J. Clin. Pharmacol. 1998, 45, 123-129.
156. Keiser, J.; Gruyer, M.-S.; Perrottet, N.; Zanolari, B.; Mercier, T.; Decosterd, L. Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica. J. Antimicrob. Chemother. 2009, 63, 543-549.
157. Nandakumar, D.N.; Nagaraj, V.A.; Vathsala, P.G.; Rangarajan, P.; Padmanaban, G. Curcumin- Artemisinin Combination Therapy for Malaria. Antimicrob. Agents Chemother. 2006, 50, 1859-1860.
158. Lai, J.-P.; Lim, Y.H.; Su, J.; Shen, H.-M.; Ong, C.N. Identification and characterization of major flavonoids and caffeoylquinic acids in three Compositae plants by LC/DAD-APCI/MS. J. Chrom. B 2007, 848, 215-225.
159. Dupuy, J.; Larrieu, G.; Sutra, J.F.; Lespine, A.; Alvinerie, M. Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet. Parasitol. 2003, 112, 337-347.
160. Stermitz, F.R.; Scriven, L.N.; Tegos, G.; Lewis, K. Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Med. 2002, 68, 1140-1141.
161. Sannella, A.R.; Messori, L.; Casini, A.; Vincieri, F.F.; Bilia, A.R.; Majori, G.; Severini, C. Antimalarial properties of green tea. Biochem. Biophys. Res. Commun. 2007, 353, 177-181.
162. Gupta, S.; Thapar, M.M.; Wernsdorfer, W.H.; Bjorkman, A. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob. Agents Chemother. 2002, 46, 1510-1515.
163. de Oliveira, T.C.; Silva, D.A.O.; Rostkowska, C.; Béla, S.R.; Ferro, E.A.V.; Magalhães, P.M.; Mineo, J.R. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo. Experim. Parasitol. 2009, 122, 233-241.
164. van Agtmael, M.A.; Gupta, V.; van der Wösten, T.H.; Rutten, J.P.B.; van Boxtel, C.J. Grapefruit juice increases the bioavailability of artemether. Eur. J. Clin. Pharmacol. 1999, 55, 405-410.
165. El-Lakkany, N.M.; Seif el-Din, S.H.; Badawy, A.A.; Ebeid, F.A. Effect of artemether alone and in combination with grapefruit juice on hepatic drug-metabolising enzymes and biochemical aspects in experimental Schistosoma mansoni. Int. J. Parasitol. 2004, 34, 1405-1412.
166. Zhou, S.; Lim, L.Y.; Chowbay, B. Herbal modulation of p-glycoprotein. Drug Metab. Rev. 2004, 36, 57-104.
167. Yarnell, E.; Abascal, K. Interaction of herbal constituents with cytochrome P450 enzymes. Altern. Complem. Ther. 2007, 239-247.
168. Soh, P.N.; Witkowski, B.; Olagnier, D.; Nicolau, M.-L.; Garcia-Alvarez, M.-C.; Berry, A.; Benoit-Vical, F. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob. Agents Chemother. 2009, 53, 1100-1106.
169. Ekong, R.; Warhurst, D.C. Synergism between arteether and mefloquine or quinine in a multidrug-resistant strain of Plasmodium falciparum in vitro. Trans. Royal Soc. Trop. Med. Hyg. 1990, 84, 757-758.
170. Akoachere, M.; Buchholz, K.; Fischer, E.; Burhenne, J.; Haefeli, W.E.; Schirmer, R.H.; Becker, K. In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob. Agents Chemother. 2005, 49, 4592-4597.
171. WHO. WHO announces pharmaceutical companies agree to stop marketing single-drug artemisinin malaria pills. Available online: http://www.who.int/ mediacentre/news/releases/2006/ pr23/en/print.html/, (accessed on 29 April 2010).
172. Hsu, E. The history of qing hao in the Chinese materia medica. Transac. Royal Soc. Trop. Med. Hyg. 2006, 100, 505-508.
173. Mueller, M.S.; Runyambo, N.; Wagner, I.; Borrmann, S.; Dietz, K.; Heide, L. Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans. Royal Soc. Trop. Med. Hyg. 2004, 98, 318-321.
174. Mueller, M.S.; Karhagomba, I.B.; Hirt, H.M.; Wemakor, E. The potential of Artemisia annua L. as a locally produced remedy for malaria in the tropics: agricultural, chemical and clinical aspects. J. Ethnopharm. 2000, 73, 487-493.
175. Hollman, P.C. Evidence for health benefits of plant phenols: Local or systemic effects. J. Sci. Food Agric. 2001, 81, 842-852.
176. Atemnkeng, M.A.; Chimanuka, B.; Dejaegher, B.; Heyden, Y.V.; Plaizier-Vercammen, J. Evaluation of Artemisia annua infusion efficacy for the treatment of malaria in Plasmodium chabaudi chabaudi infected mice. Exper. Parasitol. 2009, 122, 344-348.
177. Wright, C.W.; Linley, P.A.; Brun, R.; Wittlin, S.; Hsu, E. Ancient chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of qing hao with potent antimalarial activity. Molecules 2010, 15, 804-812.
178. Dueñas, M.; Gonzàlez-Manzano, S.; Gonzàlez- Paramàs, A.; Santos-Buelga, C. Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin. J. Pharm. Biomed. Anal. 2010, 51, 443-449.
179. Kinghorn, D.A.; Farnsworth, N.; Soejarto, D.; Cordell, G.; Swanson, S.; Pezzuto, J.; Wani, M.; Wall, M.; Oberlies, N.H.; Kroll, D.; Kramer, R.; Rose, W.; Vite, G.; Fairchild, C.; Peterson, R.; Wild, R. Novel strategies for the discovery of plant-derived anticancer agents. Pharm. Biol. 2003, 41, 53-67.